PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjLink to Publisher's site
 
BMJ. 1994 May 28; 308(6941): 1407–1411.
PMCID: PMC2540391

Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.

Abstract

OBJECTIVE--To assess the effect of screening for cervical intraepithelial neoplasia on the incidence of and mortality from invasive squamous cell carcinoma of cervix in north east Scotland and to discover why cases of invasive cancer still occur. DESIGN--(a) Analysis of data on cases of cervical intraepithelial neoplasia obtained from the cytology data bank; (b) analysis of data on 612 women presenting with invasive squamous cancer during 1968-91, obtained from cancer registry and hospital records; (c) analysis of death rates obtained from the registrar general's (Scotland) annual reports, the Information Services Division of the Home and Health Department (Scotland), and local records for 1974-91; (d) case-control studies on 282 cases of invasive cancer and 108 deaths which occurred in 1982-91. Cases were matched with two controls both for age and for having a negative smear test result at the time of presentation of the case. SETTING--North east Scotland (Grampian region, Orkney, and Shetland). SUBJECTS--Women (n = 306,608) who had had cervical smear tests between 1960 and 1991. RESULTS--There had been a substantial increase in cases of cervical intraepithelial neoplasia grade III since 1982. The incidence of invasive cancer has fallen since the start of screening in 1960, the fall occurring mainly in the well screened age group 40-69 years. There was a rise in women aged under 40 and over 70. Women with invasive disease seen between 1982 and 1991 mostly presented at stage I. Of these, half were unscreened, one third were poorly screened, 11% were found in retrospect to have had abnormal cells, 3% had recurrence of disease after treatment for cervical intraepithelial neoplasia grade III, and 3% were lost to follow up. Death rates had fallen, most noticeably in women aged 45-64, who had had the opportunity to be screened and rescreened. There was a disturbing rise in deaths among women under 45. Most deaths (65%) occurred in unscreened women. Case-control studies showed that the longer the time and absence of a smear test before presentation the higher was the risk of invasive cancer and of death. CONCLUSIONS--Screening has been effective in reducing the incidence of and mortality from cervical cancer in north east Scotland. Most cases and deaths occurred in unscreened women or in those who had had few smears at long intervals. An increase in cases of cervical intraepithelial neoplasia grade III in women screened for the first time occurred during 1982-91.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Macgregor JE, Baird D. Detection of Cervical Carcinoma in the General Population. Br Med J. 1963 Jun 22;1(5346):1631–1636. [PMC free article] [PubMed]
  • LAWSON JG. Cancer of the uterine cervix: some factors influencing survival rates. J Obstet Gynaecol Br Emp. 1956 Dec;63(6):819–825. [PubMed]
  • Cotton RE, Elwood JM, Jones GM. Results of delayed follow up of abnormal cervical smears. Br Med J (Clin Res Ed) 1986 Mar 22;292(6523):799–800. [PMC free article] [PubMed]
  • Anderson DJ, Flannelly GM, Kitchener HC, Fisher PM, Mann EM, Campbell MK, Templeton A. Mild and moderate dyskaryosis: can women be selected for colposcopy on the basis of social criteria? BMJ. 1992 Jul 11;305(6845):84–87. [PMC free article] [PubMed]
  • Bethwaite P, Yeong ML, Holloway L, Robson B, Duncan G, Lamb D. The prognosis of adenosquamous carcinomas of the uterine cervix. Br J Obstet Gynaecol. 1992 Sep;99(9):745–750. [PubMed]
  • Cook GA, Draper GJ. Trends in cervical cancer and carcinoma in situ in Great Britain. Br J Cancer. 1984 Sep;50(3):367–375. [PMC free article] [PubMed]
  • Anderson GH, Boyes DA, Benedet JL, Le Riche JC, Matisic JP, Suen KC, Worth AJ, Millner A, Bennett OM. Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85. Br Med J (Clin Res Ed) 1988 Apr 2;296(6627):975–978. [PMC free article] [PubMed]
  • Lără E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1987 May 30;1(8544):1247–1249. [PubMed]
  • Van Wijngaarden WJ, Duncan ID. Rationale for stopping cervical screening in women over 50. BMJ. 1993 Apr 10;306(6883):967–971. [PMC free article] [PubMed]
  • van Oortmarssen GJ, Habbema JD, van Ballegooijen M. Predicting mortality from cervical cancer after negative smear test results. BMJ. 1992 Aug 22;305(6851):449–451. [PMC free article] [PubMed]
  • Macgregor JE. False negative cervical smears. Br J Obstet Gynaecol. 1993 Sep;100(9):801–802. [PubMed]
  • Jha PK, Beral V, Peto J, Hack S, Hermon C, Deacon J, Mant D, Chilvers C, Vessey MP, Pike MC, et al. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet. 1993 May 1;341(8853):1116–1118. [PubMed]
  • Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]. Lancet. 1992 Apr 18;339(8799):959–960. [PubMed]
  • Cooper P, Kirby AJ, Spiegelhalter DJ, Whitehead AL, Patterson A. Management of women with a cervical smear showing a mild degree of dyskaryosis: a review of policy. Cytopathology. 1992;3(6):331–339. [PubMed]
  • Silcocks PB, Moss SM. Rapidly progressive cervical cancer: is it a real problem? Br J Obstet Gynaecol. 1988 Nov;95(11):1111–1116. [PubMed]
  • Husain OA, Butler EB, Evans DM, Macgregor JE, Yule R. Quality control in cervical cytology. J Clin Pathol. 1974 Dec;27(12):935–944. [PMC free article] [PubMed]
  • Coppleson LW, Brown B. Estimation of the screening error rate from the observed detection rates in repeated cercival cytology. Am J Obstet Gynecol. 1974 Aug 1;119(7):953–958. [PubMed]
  • Berkeley AS, LiVolsi VA, Schwartz PE. Advanced squamous cell carcinoma of the cervix with recent normal Papanicolaou tests. Lancet. 1980 Aug 16;2(8190):375–376. [PubMed]
  • Macgregor JE. What constitutes an adequate cervical smear? Br J Obstet Gynaecol. 1991 Jan;98(1):6–7. [PubMed]
  • Robertson AJ, Anderson JM, Beck JS, Burnett RA, Howatson SR, Lee FD, Lessells AM, McLaren KM, Moss SM, Simpson JG, et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol. 1989 Mar;42(3):231–238. [PMC free article] [PubMed]
  • Kirby AJ, Spiegelhalter DJ, Day NE, Fenton L, Swanson K, Mann EM, Macgregor JE. Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet. 1992 Apr 4;339(8797):828–831. [PubMed]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Group